News

Our consultant Munna Choudhury attended the FierceBiotech Executive Summit in London on Tuesday 30th October 2018. She was a speaker on the panel discussing challenges and opportunities for Life Sciences after Brexit; Munna’s particular focus was on the Digital Healthcare and the pharma landscape in the context of an ageing population seeking faster, better andRead more

Munna Choudhury of Alacramed will be attending the Fierce Biotech UK Summit on 30th October 2018. She will be a panel member in a forum discussing the topic: Tapping Britain’s Digital Health Industry. Please contact us if you would like to arrange a meeting with Munna.

Alacramed’s work on the Medical Technologies Science & Innovation Audit (Leeds City Region)(1), sponsored by the Department for Business, Energy and Industrial Strategy, identified technology convergence as being one of the leading drivers in the growth of the global medtech industry. The combining of technologies such as artificial intelligence, wireless communication, mobile health apps and wearables forRead more

Medtech’s growing influence on pharma By Dr Munna Choudhury, and Dr Mark Wickham, MBA There is no doubt that medtech/pharma deals increasingly appear in the news and that new medtech products and advancements in digital & connected health technologies are being heralded as value-adds to medicines. But what is the real value ofRead more

By Munna Choudhury, PhD Almost 47 million people live with dementia worldwide and it is one of the key causes of disability later in life beating cancer, cardiovascular disease and strokes. This number is likely to double by 2030 and almost triple by 2050 (1). There are many different types of dementia, the mostRead more

We are a specialist medical device consultancy consisting of industry experts with long and successful track records in commercialising medical device products. We have broad functional and sector experience, and would welcome an opportunity to discuss with you any challenge relating to creating sustainable value from medical technologies.